Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017

Details for Mechanism ID: 14113
Country/Region: Malawi
Year: 2014
Main Partner: Elizabeth Glaser Pediatric AIDS Foundation
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $2,888,536 Additional Pipeline Funding: N/A

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

Through the Service Delivery, Quality Improvement and Health Systems Strengthening Program, EGPAF will scale up high quality, comprehensive HIV prevention and treatment services at 150 health facilities in seven target districts. The program has identified and will address the service delivery gaps that prevent quality HIV prevention, care and treatment services. EGPAF will improve the delivery of services, particularly the implementation of Option B+. The expected reduction in new HIV infections and morbidity and mortality will be realized through increasing the effectiveness, sustainability, equity and efficiency of district-based planning, budgeting and implementation processes in zones and districts, and supporting evidence-based prevention, care and treatment interventions at the facility level. This program will be fully aligned with district health service and budget planning processes to ensure full harmonization and district level ownership. Elements of this program include increasing alignment with government, and mutual accountability through directly funding zones or districts through sub-grants, while carefully monitoring performance, providing direct financial and technical support to strengthen planning, budgeting, financial and expenditure processes, and integrating strategic information more effectively and directly in district planning. This program supports the provision of needed HIV services, promotes improved health services through strengthening leadership and governance, the health workforce, information systems, laboratory and other health system components at the district level by supporting specific critical health services across multiple disease areas consistent with priorities identified in Malawi’s Health Sector and HIV Strategic Plans.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $469,686
Care: TB/HIV (HVTB) $126,240
Care: Pediatric Care and Support (PDCS) $36,000
Laboratory Infrastructure (HLAB) $68,630
Health Systems Strengthening (OHSS) $60,000
Testing: HIV Testing and Counseling (HVCT) $238,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $140,000
Treatment: Adult Treatment (HTXS) $1,460,000
Treatment: Pediatric Treatment (PDTX) $289,980
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
C2.1.D By Age: <15 2015 1,880
C2.1.D By Age: <15 2015 3,931
C2.1.D By Age: 15+ 2015 21,534
C2.1.D By Age: 15+ 2015 57,161
C2.1.D By Age/Sex: <15 Female 2015 1,239
C2.1.D By Age/Sex: <15 Female 2015 1,965
C2.1.D By Age/Sex: <15 Male 2015 641
C2.1.D By Age/Sex: <15 Male 2015 1,965
C2.1.D By Age/Sex: 15+ Female 2015 14,101
C2.1.D By Age/Sex: 15+ Female 2015 36,583
C2.1.D By Age/Sex: 15+ Male 2015 7,433
C2.1.D By Age/Sex: 15+ Male 2015 20,579
C2.1.D By Sex: Female 2015 15,340
C2.1.D By Sex: Female 2015 38,549
C2.1.D By Sex: Male 2015 8,074
C2.1.D By Sex: Male 2015 22,543
C2.1.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 23,414
C2.1.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 61,092
C2.1.D Sum of Age disaggregates 2015 23,414
C2.1.D Sum of Age disaggregates 2015 61,092
C2.1.D Sum of Age/Sex disaggregates 2015 23,414
C2.1.D Sum of Age/Sex disaggregates 2015 61,092
C2.1.D Sum of Sex disaggregates 2015 23,414
C2.1.D Sum of Sex disaggregates 2015 61,092
C2.1.D_NGI By Age: <15 2015 6,040
C2.1.D_NGI By Age: 15+ 2015 64,702
C2.1.D_NGI By Age/Sex: <15 Female 2015 3,889
C2.1.D_NGI By Age/Sex: <15 Male 2015 2,151
C2.1.D_NGI By Age/Sex: 15+ Female 2015 41,767
C2.1.D_NGI By Age/Sex: 15+ Male 2015 22,935
C2.1.D_NGI By Sex: Female 2015 45,656
C2.1.D_NGI By Sex: Male 2015 25,086
C2.1.D_NGI Number of HIV-positive individuals receiving a minimum of one clinical service 2015 70,742
C2.1.D_NGI Sum of Age disaggregates 2015 70,742
C2.1.D_NGI Sum of Age/Sex disaggregates 2015 70,742
C2.1.D_NGI Sum of Sex disaggregates 2015 70,742
C2.4.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 61,092
C2.4.D Number of HIV-positive patients who were screened for TB in HIV care or treatment setting 2015 58,037
C2.5.D Number of HIV-positive individuals receiving a minimum of one clinical service 2015 61,092
C2.5.D Number of HIV-positive patients in HIV care who started TB treatment 2015 580
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 1,239
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 2,556
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 641
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 2,556
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 14,101
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 28,630
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 7,433
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 17,382
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 23,414
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 51,124
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2015 23,414
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2015 51,124
CARE_NEW Aggregated Age/sex: <15 Female 2015 1,483
CARE_NEW Aggregated Age/sex: <15 Male 2015 1,483
CARE_NEW Aggregated Age/sex: 15+ Female 2015 16,611
CARE_NEW Aggregated Age/sex: 15+ Male 2015 10,086
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 29,663
CARE_NEW Sum of Aggregated Age/sex disaggregates 2015 29,663
CARE_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 66
CARE_SITE By site support type: Technical Assistance-only (TA): Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 85
CARE_SITE Number of PEPFAR-supported HIV clinical care sites at which at least 80% of PLHIV received all of the following during the reporting period: 1) clinical assessment (WHO staging) OR CD4 count OR viral load, AND 2) TB screening at last visit, AND 3) if eligible, cotrimoxazole 2015 151
CARE_SITE Sum of Numerator Site Support Type disaggregates 2015 151
CARE_SITE Total number of PEPFAR supported sites providing clinical care services 2015 151
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 53,939
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 11,222
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 2,245
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2015 11,222
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 120,752
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 154,853
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 5,135
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 82,650
HTS_TST Aggregated Age/sex: <15 Female 2015 116,943
HTS_TST Aggregated Age/sex: <15 Male 2015 5,762
HTS_TST Aggregated Age/sex: 15+ Female 2015 270,500
HTS_TST Aggregated Age/sex: 15+ Male 2015 12,920
HTS_TST By Test Result: Negative 2015 171,147
HTS_TST By Test Result: Negative 2015 381,757
HTS_TST By Test Result: Negative 2015 233,952
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 182,071
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 406,125
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 259,947
HTS_TST Sum of Aggregated Age/Sex <15 2015 56,184
HTS_TST Sum of Aggregated Age/Sex <15 2015 122,705
HTS_TST Sum of Aggregated Age/Sex <15 2015 22,444
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 125,887
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 283,420
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 237,503
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 182,071
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 406,125
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 259,947
HTS_TST Sum of Test Result disaggregates 2015 182,071
HTS_TST Sum of Test Result disaggregates 2015 406,125
HTS_TST Sum of Test Result disaggregates 2015 259,947
HTS_TST_POS By Test Result: Positive 2015 10,924
HTS_TST_POS By Test Result: Positive 2015 24,368
HTS_TST_POS By Test Result: Positive 2015 25,995
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2015 10,000
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2015 10,000
LAB_ACC By site support type: Direct Service Delivery (DSD) 2015 16
LAB_ACC By site support type: Technical Assistance-only (TA) 2015 4
LAB_ACC Number of PEPFAR-supported testing facilities (laboratories) that are recognized by national, regional, or international standards for accreditation or have achieved a minimal acceptable level towards attainment of such accreditation 2015 20
LAB_ACC Sum of Support Type disaggregates 2015 20
LAB_CAP By site support type: Direct Service Delivery (DSD) 2015 16
LAB_CAP By site support type: Technical Assistance-only (TA) 2015 4
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2015 20
LAB_CAP Sum of Site Support Type disaggregates 2015 20
PMTCT_ARV Life-long ART (including Option B+) 2015 2,150
PMTCT_ARV Life-long ART (including Option B+) 2015 3,849
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 2,300
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 4,181
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 2,150
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 3,849
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 770
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 1,925
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 1,380
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 1,924
PMTCT_ARV Sum of New and Current disaggregates 2015 2,150
PMTCT_ARV Sum of New and Current disaggregates 2015 3,849
PMTCT_ARV Sum of Regimen Type disaggregates 2015 2,150
PMTCT_ARV Sum of Regimen Type disaggregates 2015 3,849
PMTCT_ARV_NGI Life-long ART (including Option B+) 2015 5,500
PMTCT_ARV_NGI Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 6,000
PMTCT_ARV_NGI Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 5,500
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 2,200
PMTCT_ARV_NGI Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 3,300
PMTCT_ARV_NGI Sum of New and Current disaggregates 2015 5,500
PMTCT_ARV_NGI Sum of Regimen disaggregates 2015 5,500
PMTCT_EID By infants who received a virologic test within 2 months of birth 2015 120
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2015 1,080
PMTCT_EID By infants with a positive virologic test result within 12 months of birth 2015 120
PMTCT_EID Number of HIV- positive pregnant women identified during the reporting period (include known HIV-positive women at entry into PMTCT) 2015 4,181
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2015 2,091
PMTCT_EID Sum of Infant Age disaggregates 2015 1,200
PMTCT_SITE By site support type: Direct Service Delivery (DSD): Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women 2015 63
PMTCT_SITE By site support type: Direct Service Delivery (DSD): Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) 2015 63
PMTCT_SITE Number of PEPFAR-supported sites achieving 90% ARV or ART coverage for HIV+ pregnant women 2015 63
PMTCT_SITE Sum of Numerator Support Type disaggregates 2015 63
PMTCT_SITE Total number of PEPFAR supported sites providing PMTCT services (HTC and ARV or ART services) 2015 63
PMTCT_SITE_den Sum of Denominator Support Type disaggregates 2015 63
PMTCT_STAT By: Known positives at entry 2015 1,392
PMTCT_STAT By: Known positives at entry 2015 1,965
PMTCT_STAT By: Number of new positives identified 2015 2,088
PMTCT_STAT By: Number of new positives identified 2015 2,216
PMTCT_STAT Number of new ANC and L&D clients 2015 75,440
PMTCT_STAT Number of new ANC and L&D clients 2015 86,290
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 58,000
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 80,342
PMTCT_STAT Sum of Positives Status disaggregates 2015 3,480
PMTCT_STAT Sum of Positives Status disaggregates 2015 4,181
PMTCT_STAT_NGI By: Known positives at entry 2015 2,880
PMTCT_STAT_NGI By: Number of new positives identified 2015 4,320
PMTCT_STAT_NGI Number of new ANC and L&D clients 2015 160,000
PMTCT_STAT_NGI Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 120,000
PMTCT_STAT_NGI Sum of Positives Status disaggregates 2015 7,200
SITE_SUPP By program area/support type: Care and Support Direct Service Delivery (DSD) 2015 65
SITE_SUPP By program area/support type: HTC Direct Service Delivery (DSD) 2015 65
SITE_SUPP By program area/support type: HTC Technical Assistance-only (TA) 2015 65
SITE_SUPP By program area/support type: Lab Direct Service Delivery (DSD) 2015 16
SITE_SUPP By program area/support type: Lab Technical Assistance-only (TA) 2015 4
SITE_SUPP By program area/support type: PMTCT Direct Service Delivery (DSD) 2015 65
SITE_SUPP By program area/support type: TB/HIV Direct Service Delivery (DSD) 2015 65
SITE_SUPP By program area/support type: Treatment Direct Service Delivery (DSD) 2015 65
SITE_SUPP By program area/support type: Treatment Technical Assistance-only (TA) 2015 65
SITE_SUPP Number of unique sites supported by PEPFAR 2015 65
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2015 51,124
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2015 50,613
TX_CURR Aggregated Age/Sex: <15 Female 2015 1,239
TX_CURR Aggregated Age/Sex: <15 Female 2015 2,199
TX_CURR Aggregated Age/Sex: <15 Male 2015 641
TX_CURR Aggregated Age/Sex: <15 Male 2015 2,199
TX_CURR Aggregated Age/Sex: 15+ Female 2015 14,101
TX_CURR Aggregated Age/Sex: 15+ Female 2015 32,016
TX_CURR Aggregated Age/Sex: 15+ Male 2015 7,433
TX_CURR Aggregated Age/Sex: 15+ Male 2015 17,239
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 23,414
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 53,653
TX_CURR Sum of Aggregated Age/Sex <15 2015 1,880
TX_CURR Sum of Aggregated Age/Sex <15 2015 4,398
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 21,534
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 49,255
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 23,414
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 53,653
TX_CURR_NGI Aggregated Age/Sex: <15 Female 2015 3,889
TX_CURR_NGI Aggregated Age/Sex: <15 Male 2015 2,151
TX_CURR_NGI Aggregated Age/Sex: 15+ Female 2015 41,767
TX_CURR_NGI Aggregated Age/Sex: 15+ Male 2015 22,935
TX_CURR_NGI Number of adults and children receiving antiretroviral therapy (ART) 2015 70,742
TX_CURR_NGI Sum of Aggregated Age/Sex <15 2015 6,040
TX_CURR_NGI Sum of Aggregated Age/Sex 15+ 2015 64,702
TX_CURR_NGI Sum of Aggregated Age/Sex disaggregates 2015 70,742
TX_NEW Aggregated Grouping by Age: <1 Male 2015 49
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2015 49
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2015 493
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2015 493
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2015 7,907
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2015 4,397
TX_NEW Breastfeeding status 2015 797
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2015 13,290
TX_NEW Pregnancy status 2015 2,791
TX_NEW Sum of Aggregated Age/Sex disaggregates 2015 13,290
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2015 10,898
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2015 13,290
TX_SITE By support type: Direct Service Delivery (DSD): Total number of PEPFAR-supported ART sites 2015 63
TX_SITE Number of PEPFAR-supported ART sites with a retention rate of 75% or greater for patients 12 months after ART initiation 2015 63
TX_SITE Total number of PEPFAR-supported ART sites 2015 63
TX_SITE_den Sum of Denominator Site Support Type disaggregates 2015 63
Cross Cutting Budget Categories and Known Amounts Total: $36,000
Human Resources for Health $36,000
Key Issues Identified in Mechanism
Child Survival Activities
Safe Motherhood
Tuberculosis
Family Planning